Dr. Gottlieb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
501 Gordon Dr
Exton, PA 19341Phone+1 610-594-6660Fax+1 610-594-6810
Education & Training
University of Pennsylvania Health SystemResidency, Dermatology, 1995 - 1998
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
Weill Cornell MedicineClass of 1990
Certifications & Licensure
NY State Medical License 2002 - 2026
NJ State Medical License 1997 - 2025
PA State Medical License 1994 - 2024- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Top MD Consumers Checkbook
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
- Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
- Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis Start of enrollment: 2019 Oct 29
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsA Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).Joel M. Gelfand, Daniel B. Shin, Kristina Callis Duffin, April W. Armstrong, Andrew Blauvelt
The Journal of Investigative Dermatology. 2020-09-01 - 35 citationsCellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell‐mediated inflammation are unexpected outcomesScott L. Gottlieb, Elizabeth Hayes, Patricia Gilleaudeau, Irma Cardinale, Alice B. Gottlieb
Journal of Cutaneous Pathology. 1996-10-01 - 447 citationsResponse of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.Scott L. Gottlieb, Patricia Gilleaudeau, Ray Johnson, Len Estes, Thasia G. Woodworth
Nature Medicine. 1995-05-01
Press Mentions
With COVID-19 Cases on Rise Again, Pennsylvania Officials Concerned About Thanksgiving SurgeNovember 15th, 2021- Ross: COVID Vaccine Booster Mixed Messaging Is the Worst Misstep of the PandemicNovember 15th, 2021
- The Rate of Covid-19 Cases Is Dropping Nationally but Rising in These 5 StatesOctober 10th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
